Astrazeneca (AZN) Exchange Rate Effect (2009 - 2026)

Astrazeneca's Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$18.0 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 172.0% year-over-year to -$18.0 million; the TTM figure through Mar 2026 stood at $3.0 million (up 113.64% YoY), while the FY2025 annual figure was $46.0 million, up 149.46% from the prior year.
• Exchange Rate Effect was -$18.0 million for Q1 2026 at Astrazeneca, down from $4.0 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $29.0 million in Q2 2025 to a low of -$61.0 million in Q4 2024.
• Historically, Exchange Rate Effect has averaged -$11.3 million across 5 years, with a median of -$11.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect tumbled 318.18% in 2024, then jumped 583.33% in 2025.
• A 5-year view of Exchange Rate Effect shows it stood at -$26.0 million in 2022, then tumbled by 38.46% to -$36.0 million in 2023, then tumbled by 69.44% to -$61.0 million in 2024, then surged by 106.56% to $4.0 million in 2025, then slumped by 550.0% to -$18.0 million in 2026.
• The last three Exchange Rate Effect figures came in at -$18.0 million (Q1 2026), $4.0 million (Q4 2025), and -$12.0 million (Q3 2025), per Business Quant data.